D Koya

Summary

Affiliation: Kanazawa Medical University
Country: Japan

Publications

  1. ncbi Sirtuins as possible drug targets in type 2 diabetes
    Munehiro Kitada
    Division of Diabetology and Endocrinology, Kanazawa Medical University, Kahoku gun, Ishikawa prefecture 920 0293, Japan
    Curr Drug Targets 14:622-36. 2013
  2. ncbi Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
    Megumi Kanasaki
    Division of Diabetes and Endocrinology, Kanazawa Medical University, Uchinada, Ishikawa, Japan
    Fibrogenesis Tissue Repair 4:25. 2011
  3. ncbi Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial
    D Koya
    Kanazawa Medical University, Uchinadacho, Kahokugun, Ishikawa, Japan
    Diabetologia 52:2037-45. 2009
  4. ncbi SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications
    Shinji Kume
    Department of Medicine, Shiga University of Medical Science, Otsu, Japan
    Endocr Metab Immune Disord Drug Targets 10:16-24. 2010

Collaborators

  • Y Tomino
  • H Makino
  • Y Murakami
  • Munehiro Kitada
  • Shinji Kume
  • Keizo Kanasaki
  • Megumi Kanasaki
  • Ai Takeda-Watanabe
  • Takako Nagai
  • Takashi Uzu
  • Atsunori Kashiwagi

Detail Information

Publications4

  1. ncbi Sirtuins as possible drug targets in type 2 diabetes
    Munehiro Kitada
    Division of Diabetology and Endocrinology, Kanazawa Medical University, Kahoku gun, Ishikawa prefecture 920 0293, Japan
    Curr Drug Targets 14:622-36. 2013
    ..In this review, we summarize the current understanding of the biological functions of SIRT1, SIRT3 and SIRT6 in metabolism and discuss their potential role as therapeutic targets in T2DM...
  2. ncbi Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
    Megumi Kanasaki
    Division of Diabetes and Endocrinology, Kanazawa Medical University, Uchinada, Ishikawa, Japan
    Fibrogenesis Tissue Repair 4:25. 2011
    ....
  3. ncbi Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial
    D Koya
    Kanazawa Medical University, Uchinadacho, Kahokugun, Ishikawa, Japan
    Diabetologia 52:2037-45. 2009
    ..There is currently insufficient evidence to recommend a low-protein diet for type 2 diabetic patients with diabetic nephropathy. We assessed whether a low-protein diet could prevent the progression of diabetic nephropathy...
  4. ncbi SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications
    Shinji Kume
    Department of Medicine, Shiga University of Medical Science, Otsu, Japan
    Endocr Metab Immune Disord Drug Targets 10:16-24. 2010
    ..This review summarizes current understanding of the biological functions of SIRT1, and discusses its potential as a pharmacological target for fighting metabolic and vascular diseases...